Histopathologic comparison of dexmedetomidine's and thiopental's cerebral protective effects on focal cerebral ischemia in rats
Comparação histopatológica dos efeitos protetores cerebrais de dexmedetomidina e tiopental sobre isquemia cerebral focal em ratos
Ebru Çanakçı; ; Sevilay Akalp Özmen; Mustafa Ferhat Çolak; Hüsnü Kürş; ad
Abstract
Keywords
Resumo
Palavras-chave
References
Graham DI. Focal cerebral infarction. J Cereb Blood Flow Metab. 1988;8:769-73.
McIlraith DM, Cöte R. Epidemiology and etiology of stroke. Curr Opin Neurol Neurosurg. 1991;4:31-7.
Analysis of neuronal damage resulting in the focal cerebral infarct model induced by middle cerebral artery occlusion in rats and Ginkgo Biloba extract’s effects on this. 1994.
Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke. 1989;20:1627-42.
Garcia JH. Experimental ischemic stroke: a review. Stroke. 1984;15:5-14.
Grotta JC. Current medical and surgical therapy for cerebrovascular disease. N Engl J Med. 1987;317:1505-16.
Barsan WG, Brott TG, Olinger CP, Marler JR. Early treatment for acute ischemic stroke. Ann Int Med. 1989;111:449-51.
Albers GW, Goldgerg MP, Choi DW. NMDA antagonists: ready for clinical trial in brain ischemia?. Ann Neurol. 1989;25:398-403.
Wong MCW, Haley Jr. EC. Calcium antagonists: stroke therapy coming of age. Stroke. 1990;21:494-501.
William F, Cottrell JE, Smith DS. Brain metabolism. 1994:1-16.
Drummond JC, Shipiro HM, Miller RD. Cerebral physiology. 1994:689-729.
Hoffman WE, Charbel FT, Edelman G, Ausman JI. Thiopental and desflurane treatment for brain protection. Neurosurgery. 1998;43:1050-3.
Sano T, Patel PM, Drummond JC, Cole DJ. A comparison of the cerebral protective effects of etomidate, thiopental and isoflurane in a model of forebrain ischemia in the rat. Anesth Analg. 1993;76:990-7.
Cole DJ, Cross LM, Drummond JC. Thiopentone and methohexital, but not pentobarbitone, reduce early focal cerebral ischemic injury in rats. Can J Anaesth. 2001;48:807-14.
Jolkkonen J, Puurunen K, Koistinaho J. Neuroprotection by the alpha-2 adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol. 1999;372:31-6.
Hoffman WE, Kochs E, Werner C, Thomas C, Albrecht RF. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2 adrenergic antagonist atipamezole. Anesthesiology. 1991;75:328-32.
Kuhnomen J, Haapalinna A, Sivenius J. Effects of dexmedetomidine on CO2 reactivity and cerebral autoregulation in healthy volunteers. 2001.
Laudenbach V, Mantz J, Evrard P, Grassens P. Dexmedetomidine protect against neonatal exitotoxic brain injury. 2000.
Ma D, Hossain M, Franks NP, Maze M. Role of the alpha-2a adrenoceptor subtype in the neuroprotective effect of dexmedetomidine. 2003.
Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the dissector. J Microsc. 1984;134:127-36.
Drummond JC, Cole DJ, Patel PM, Reynolds LW. Focal cerabral ischemia during anesthesia with etomidate, isoflurane, orthiopental: a comparison of the extent of cerabral injury. Neurosurgery. 1995;37:472-9.
Coyle P. Middle cerebral artery occlusion in the young rat. Stroke. 1982;13:855-8.
Zervas NT, Hori H, Negora M. Reduction of brain dopamine following experimental cerebral ischemia. Nature. 1974;247:283-4.
Hillered L, Hallström A, Segersuard S. Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J Cereb Blood Flow Metab. 1989;9:607-16.
Makarenko NV. Higher nervous activity in dogs reanimated after long periods of clinical death from drowning and loss of blood. Zurnal Vyssej Nervnoj Dejatelvnosti. 1972;22:82-8.
Chen ST, Hsu CY, Hogan EL. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 1986;17:738-43.
Bederson BJ, Pitts HL. Rat middle cerebral artery occlusion; evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472-6.
Kogure K. Molecular and biochemical events within the brain subjected to cerebral ischemia (targets for therapeutical intervention). Clin Neurosci. 1997;4:179-83.
Ishiyama T, Dohi S, Iida H, Watanabe Y, Shimonaka H. Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth Analg. 1995;81:1208-15.
Kuhmonen J, Haapalinna A, Sivenius J. Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. J Neural Transm. 2001;108:261-71.
Engelhard K, Werner C, Kaspar S. Effect of the α2 agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology. 2002;96:450-7.
Engelhard K, Wernwer C, Kaspar S. The effect of the α2 agonist dexmedetomidine and the N-methyl-aspartate agonists S+-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg. 2003;96:524-31.
Globus MJ, Busto R, Dietrich WD, Martines E, Valdez I, Ginsberg MD. Direct evidence for acute and massive norepinephrine release in the hippocampus during transient ischemia. J Cereb Blood Flow Metab. 1989;9:892-6.
Kuhmonen J, Pokorny J, Miettinen R. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology. 1997;87:371-7.
Maier C, Steinberg GK, Sun GH, Zhi GT, Maze M. Neuroprotection by the α2-adrenoceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology. 1993;79:306-12.
Chen Y, Zhao Z, Code WE, Hertz L. A correlation between dexmedetomidine-induced biphasic increases in free cytosolic calcium concentration and energy metabolism astrocytes. Anesth Analg. 2000;91:353-7.
Talke P, Chen R, Thomas B. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90:834-9.
Steen PA, Milde JH, Michenfelder JD. No barbiturate protection in a dog model of complete cerebral ischemia. Ann Neurol. 1979;5:343-9.
Elsaesser RS, Schröder M, zausinger S, Hungerhuber E, Baethmann A, Reulen HJ. EEG burst suppression is not necessary for maximum barbiturate protection in transient focal cerabral ischemia in a rat. J Neurological Sci. 1999;162:14-9.
Xue Q, Yu B, Wang Z. Effects of ketamine, midazolam, thiopental, and propofol on brain ischemia injury in rat cerebral cortical slices. Acta Pharmacol Sin. 2004;25:115-20.
Lianhua C, Qinyan G, Changsi X. Effects of propofol, midazolam and thiopental sodium on outcome and amino acids accumulation in focal cerebral ischemia-reperfusion in rats. Chin Med J. 2003;116:292-6.